Patents by Inventor Jesus Chicharro Gonzalo

Jesus Chicharro Gonzalo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7674808
    Abstract: 4-pyridone (4-pyridinone) derivatives of Formula I and pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical formulations thereof and their use in chemotherapy of certain parasitic infections such as malaria, are provided.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: March 9, 2010
    Assignee: Glaxo Group Limited
    Inventors: Jose Maria Bueno Calderon, Jesus Chicharro Gonzalo, Milagros Lorenzo Garcia, M Pilar Manzano Chinchon
  • Patent number: 7629365
    Abstract: 3-Chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H)-pyridinone, having the following formula: is described along with its pharmaceutically acceptable salts, processes for its preparation, pharmaceutical formulations thereof and its uses in treatment of certain parasitic infections such as malaria.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: December 8, 2009
    Assignee: Glaxo Group Limited
    Inventors: Jose Maria Bueno Calderon, Jesus Chicharro Gonzalo, M Pilar Manzano Chinchon
  • Publication number: 20080021073
    Abstract: 4-pyridone (4-pyridinone) derivatives of Formula I and pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical formulations thereof and their use in chemotherapy of certain parasitic infections such as malaria, are provided.
    Type: Application
    Filed: May 29, 2007
    Publication date: January 24, 2008
    Inventors: Jose Bueno Calderon, Jesus Chicharro Gonzalo, Milagros Lorenzo Garcia, M. Manzano Chinchon
  • Publication number: 20070281977
    Abstract: 3-Chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H)-pyridinone, having the following formula: is described along with its pharmaceutically acceptable salts, processes for its preparation, pharmaceutical formulations thereof and its uses in treatment of certain parasitic infections such as malaria.
    Type: Application
    Filed: May 31, 2007
    Publication date: December 6, 2007
    Inventors: Jose Bueno Calderon, Jesus Chicharro Gonzalo, M Manzano Chinchon
  • Patent number: 6410528
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts and or metabolically labile derivatives thereof, wherein R1 represents C1-6 straight or branched chain alkyl, C1-6 straight or branched chain alkoxy, optionally substituted phenoxy, C3-6straight or branched chain alkenyloxy or C1-4 straight or branched alkoxy substituted by an optionally substituted phenyl group. C3-6 straight or branched chain alkenyl, optionally substituted phenyl, optionally substituted C3-7 cycloalkyl, C2-4 straight or branched chain alkyl substituted by (C1-4 alkoxy, C1-4 alkyl thio or halogen), C1-4 straight or branched chain alkyl substituted by (C1-4 alkoxycarbonyl, aryloxycarbonyl, cyano, optionally substituted C3-7 cycloalkyl, optionally substituted 5 or 6 membered heteroaryl, or 1 or 2 optionally substituted phenyl groups), a process for their preparation and their use in medicine.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: June 25, 2002
    Assignee: Glaxo Wellcome S.A.
    Inventors: Jose M. Bueno, Jesus Chicharro Gonzalo, Jose-Miguel Coteron, Juan Carlos Cuevas, Jose M. Fiandor, Araceli Mallo
  • Patent number: 6177457
    Abstract: A process for preparing compounds of the formula: and intermediates for use in the process.
    Type: Grant
    Filed: December 8, 1998
    Date of Patent: January 23, 2001
    Assignee: Glaxo Wellcome S.A.
    Inventors: Jose Maria Bueno Calderon, Jesus Chicharro Gonzalo, Jose Fiandor Roman, Sophie Huss, Brian Arthur Michael Rudd
  • Patent number: 6054478
    Abstract: Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: April 25, 2000
    Assignee: Glaxo Wellcome S.A.
    Inventors: Jose J. Martin, Jesus Chicharro Gonzalo, Jose R. R. Gomez, Silvestre Garcia-Ochoa Dorado, Federico Gomez De Las Heras, Michael V. Hayes, Michael J. Dawson, Howard G. Wildman, Richard M. Hall